COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis (Simplify 1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01969838
Recruitment Status : Completed
First Posted : October 25, 2013
Last Update Posted : April 15, 2020
Information provided by (Responsible Party):
Sierra Oncology, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 12, 2016
Actual Study Completion Date : May 2, 2019
Certification/Extension First Submitted : January 5, 2017